SCHEMBL20835546

SCHEMBL20835546

CCOC(=O)[C@@]1(CO)CC[C@@H](c2cccc(F)c2)N1C(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 2/20 0.42
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
GPR119 Q8TDV5 1/20 0.38
CPB2 Q96IY4 1/20 0.37
CALCRL Q16602 1/20 0.37
LMNA P02545 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PDE5A O76074 1/20 0.36
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20835589 0.87 PKM (0.43) RIPK1ALDH1A1MEN1KMT2ABCHE
SCHEMBL28515805 0.82 CALCRL (0.47) RIPK1ALDH1A1MEN1KMT2ATDP1
SCHEMBL20835838 0.78 ABCB1 (0.45) RIPK1ACHEGPR119
SCHEMBL28529951 0.78 RIPK1 (0.44) RIPK1ALDH1A1BCHEACHETDP1
SCHEMBL31479820 0.77 RIPK1 (0.47) RIPK1ALDH1A1MEN1KMT2AGPR119
SCHEMBL28515213 0.75 PKM (0.41) RIPK1ALDH1A1MEN1KMT2AGPR119
SCHEMBL2584143 0.73 RIPK1 (0.46) RIPK1ALDH1A1BCHEACHETDP1
SCHEMBL949662 0.72 NTRK1 (0.38) RIPK1
SCHEMBL934142 0.72 NTRK1 (0.38) RIPK1
SCHEMBL28517243 0.72 RIPK1 (0.44) RIPK1ALDH1A1BCHEACHETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10995084-B2 Pyrrolidine derivative KISSEI PHARMACEUTICAL CO., LTD. (JP) 2021-05-04 US disclosed
CN-109476639-B Pyrrolidine derivatives 橘生药品工业股份有限公司 2021-02-26 CN disclosed
US-20200299273-A1 PYRROLIDINE DERIVATIVE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2020-09-24 US disclosed
EP-3459941-A1 PYRROLIDINE DERIVATIVE Kissei Pharmaceutical Co., Ltd. (JP) 2019-03-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200299273-A1 PYRROLIDINE DERIVATIVE CALCRL, NPY1R, GRPR RIPK1 1917/4885ALDH1A1 2551/4885MEN1 1436/4885
US-10995084-B2 Pyrrolidine derivative CALCRL, NPY1R, GRPR RIPK1 1917/4885ALDH1A1 2551/4885MEN1 1436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.